Dr. Pagdin Bioidentical Hormone Replacement Therapy for Women

Principal Investigator:

Grant Pagdin, MD.  Canadian board-certified in Family Medicine, American Academy of Anti-Aging and Regenerative Medicine (ABAARM).  Fellowship in Family Medicine (FCFP).  Fellowship in Stem Cell Medicine.  Fellow with the Interventional Orthobiologics Foundation.

Study Abstract:

Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions.  BHRT products are prescribed by clinicians and prepared by compounding pharmacies.  This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months.  Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale.  Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.

Study Type:

Quality Improvement, Interventional, Open-Ended

Circle Benefits:

Collaboration with nationally recognized musculoskeletal physicians.  Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.  Drive superior patient education and engagement.  Legal/regulatory compliance.  Support payer negotiations.

Real-World Data Surveys:

Cervantes Short-Form Scale; Heavy Menstrual Bleeding-Visual Analog Scale

Circle Type:

Private Circle

Interested in learning more about this Circle?

Dr. Pagdin Bioidentical Hormone Replacement Therapy for Women

Circle Objective Abstract:

Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions.  BHRT products are prescribed by clinicians and prepared by compounding pharmacies.  This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months.  Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale.  Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.

Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions. BHRT products are prescribed by clinicians and prepared by compounding pharmacies. This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months. Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale. Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.

Real-World Data Surveys:

Clinically significant reduction in scores collected from the Cervantes Short-Form Scale at 6-months post-treatment.

C-SF; HMB-VAS

Intervention:

Endocrinologists, family practice and other primary care physicians, compounding pharmacies, obstetricians- gynecologists, advanced practice nurses and physicians assistants.

Bioidentical Hormone Replacement Therapy (BHRT)

Circle Benefits:

Collaboration with nationally recognized musculoskeletal physicians.  Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.  Drive superior patient education and engagement.  Legal/regulatory compliance.  Support payer negotiations.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:

Private Circle

Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES